IBIO

SEC source: 0001104659-26-116321 · tm2627695-5_4seq1.xml · derivative · entry 1

Kropotova Alexandra · CIK 0001825323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2036-10-13

F1 · security: The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · shares: The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.exercise_date: The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001104659-26-116322 · tm2627695-6_4seq1.xml · derivative · entry 1

Stoner Elizabeth · CIK 0001415739 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2036-10-13

F1 · security: The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · shares: The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

F1 · derivative.exercise_date: The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001104659-26-090344 · tm2621854-2_4seq1.xml · derivative · entry 1

Carr Molly · CIK 0002147544 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430,000

Underlying: Common Stock · 430,000 shares

Expires 2036-07-30

F1 · security: Stock option granted as an inducement award to the Reporting Person that was granted outside of the iBio, Inc. 2023 Omnibus Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4) on July 31, 2026 (the "Grant Date").

F2 · derivative.exercise_date: Vesting 25% on the one-year anniversary of the Grant Date, with an additional 6.25% vesting every three months thereafter, provided the Reporting Person remains employed by iBio, Inc. through each applicable vesting date.

SEC source: 0001104659-26-063503 · tm2615041-1_4seq1.xml · derivative · entry 1

Stoner Elizabeth · CIK 0001415739 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2036-05-17

F1 · derivative.exercise_date: Vesting monthly on a pro rata basis over 36 months.

SEC source: 0001104659-26-036093 · tm269997-1_4seq1.xml · nonDerivative · entry 2

Banjak Marc · CIK 0002033869 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

SEC source: 0001104659-26-036093 · tm269997-1_4seq1.xml · nonDerivative · entry 1

Banjak Marc · CIK 0002033869 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,566

SEC source: 0001104659-26-033028 · tm269462-2_4seq1.xml · nonDerivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,974

F1 · price: Represents shares of the Issuer's common stock purchased by the Reporting Person in multiple transactions at prices ranging from $2.01 through $2.02, inclusive, having a weighted average price as shown in column 4 of $2.0186. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range.

SEC source: 0001104659-26-033021 · tm269462-1_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,652

SEC source: 0001104659-26-008266 · tm264470-3_4seq1.xml · derivative · entry 1

Banjak Marc · CIK 0002033869 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,000

Underlying: Common Stock · 146,000 shares

Expires 2036-01-27

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, the remainder of the shares of common stock underlying the options granted will vest in equal quarterly installments over a 36-month period, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-26-008265 · tm264470-2_4seq1.xml · derivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,000

Underlying: Common Stock · 179,000 shares

Expires 2036-01-27

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, the remainder of the shares of common stock underlying the options granted will vest in equal quarterly installments over a 36-month period, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-26-008262 · tm264470-1_4seq1.xml · derivative · entry 1

Brenner Martin · CIK 0001770235 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479,000

Underlying: Common Stock · 479,000 shares

Expires 2036-01-27

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, the remainder of the shares of common stock underlying the options granted will vest in equal quarterly installments over a 36-month period, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-25-115408 · tm2532045-2_4seq1.xml · derivative · entry 1

Parada Antonio Bernardino Guimaraes · CIK 0002047863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-11-19

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-25-115414 · tm2532045-6_4seq1.xml · derivative · entry 1

Schimmelpennink Evert B. · CIK 0001713795 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-11-19

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-25-115411 · tm2532045-5_4seq1.xml · derivative · entry 1

Clark William D · CIK 0001355415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-11-19

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-25-115410 · tm2532045-4_4seq1.xml · derivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-11-19

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-25-115409 · tm2532045-3_4seq1.xml · derivative · entry 1

Kropotova Alexandra · CIK 0001825323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-11-19

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-25-115407 · tm2532045-1_4seq1.xml · derivative · entry 1

Arkowitz David · CIK 0001296999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-11-19

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-25-101608 · tm2529309-2_4seq1.xml · derivative · entry 1

Banjak Marc · CIK 0002033869 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-10-19

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, the remainder of the shares of common stock underlying the options granted will vest in equal quarterly installments over a 36-month period, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-25-101609 · tm2529309-3_4seq1.xml · derivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2035-10-19

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, the remainder of the shares of common stock underlying the options granted will vest in equal quarterly installments over a 36-month period, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-25-101607 · tm2529309-1_4seq1.xml · derivative · entry 1

Brenner Martin · CIK 0001770235 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2035-10-19

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, the remainder of the shares of common stock underlying the options granted will vest in equal quarterly installments over a 36-month period, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-25-016311 · tm257339-3_4seq1.xml · derivative · entry 1

Banjak Marc · CIK 0002033869 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,000

Underlying: Common Stock · 71,000 shares

Expires 2035-02-20

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F1 · derivative.exercise_date: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-25-016307 · tm257339-2_4seq1.xml · derivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,700

Underlying: Common Stock · 84,700 shares

Expires 2035-02-20

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F1 · derivative.exercise_date: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-25-016298 · tm257339-1_4seq1.xml · derivative · entry 1

Brenner Martin · CIK 0001770235 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,700

Underlying: Common Stock · 230,700 shares

Expires 2035-02-20

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F1 · derivative.exercise_date: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-25-003059 · tm253156-2_4seq1.xml · nonDerivative · entry 1

Parada Antonio Bernardino Guimaraes · CIK 0002047863 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 183,823

F1 · kind: Shares purchased by MagicRoad SGPS, Unipessoal LDA, of which the Reporting Person is the sole director and shareholder, pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.

F2 · ownership.direct: The reported securities are held directly by MagicRoad SGPS, Unipessoal LDA ("MagicRoad"). The Reporting Person is the sole director and shareholder of MagicRoad and has sole voting and investment power of MagicRoad with respect to the shares held by MagicRoad.

SEC source: 0001104659-25-003062 · tm253156-5_4seq1.xml · nonDerivative · entry 1

Banjak Marc · CIK 0002033869 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,066

F1 · kind: Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.

SEC source: 0001104659-25-003064 · tm253156-7_4seq1.xml · nonDerivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,139

F1 · kind: Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.

SEC source: 0001104659-25-003063 · tm253156-6_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,316

F1 · kind: Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.

SEC source: 0001104659-25-003061 · tm253156-4_4seq1.xml · nonDerivative · entry 1

Arkowitz David · CIK 0001296999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,382

F1 · kind: Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.

SEC source: 0001104659-25-003060 · tm253156-3_4seq1.xml · nonDerivative · entry 1

Clark William D · CIK 0001355415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,838

F1 · kind: Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.

SEC source: 0001104659-25-003058 · tm253156-1_4seq1.xml · nonDerivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,191

F1 · kind: Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.

SEC source: 0001104659-24-122595 · tm2429436-6_4seq1.xml · derivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,900

Underlying: Common Stock · 18,900 shares

Expires 2034-11-20

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-24-122593 · tm2429436-5_4seq1.xml · derivative · entry 1

Schimmelpennink Evert B. · CIK 0001713795 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,900

Underlying: Common Stock · 18,900 shares

Expires 2034-11-20

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-24-122592 · tm2429436-4_4seq1.xml · derivative · entry 1

Kropotova Alexandra · CIK 0001825323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,900

Underlying: Common Stock · 18,900 shares

Expires 2034-11-20

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-24-122590 · tm2429436-3_4seq1.xml · derivative · entry 1

Clark William D · CIK 0001355415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,900

Underlying: Common Stock · 18,900 shares

Expires 2034-11-20

F1 · security: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.

SEC source: 0001104659-24-122589 · tm2429436-2_4seq1.xml · derivative · entry 1

Arkowitz David · CIK 0001296999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,600

Underlying: Common Stock · 12,600 shares

Expires 2034-11-20

F1 · security: These options vest pro rata on a monthly basis over three years commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over three years commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over three years commencing on the date of the grant.

SEC source: 0001104659-24-126813 · tm2430052-2_4seq1.xml · derivative · entry 1

Parada Antonio Bernardino Guimaraes · CIK 0002047863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,600

Underlying: Common Stock · 12,600 shares

Expires 2034-11-20

F1 · security: These options vest pro rata on a monthly basis over three years commencing on the date of the grant.

F1 · shares: These options vest pro rata on a monthly basis over three years commencing on the date of the grant.

F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over three years commencing on the date of the grant.

SEC source: 0001104659-24-060594 · tm2414241-2_4seq1.xml · derivative · entry 2

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2034-05-09

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F2 · derivative.exercise_date: These options vest in equal amounts on a quarterly basis over a 36-month period commencing on the date of grant.

SEC source: 0001104659-24-060594 · tm2414241-2_4seq1.xml · derivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,300

Underlying: Common Stock · 147,300 shares

Expires 2034-05-09

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F1 · derivative.exercise_date: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-24-060588 · tm2414241-1_4seq1.xml · derivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2034-05-09

F1 · security: These options vest in equal amounts on a quarterly basis over a 36-month period commencing on the date of grant.

F1 · derivative.exercise_date: These options vest in equal amounts on a quarterly basis over a 36-month period commencing on the date of grant.

SEC source: 0001104659-24-053070 · tm2412866-1_4seq1.xml · derivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,800

Underlying: Common Stock · 35,800 shares

Expires 2034-04-25

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F1 · derivative.exercise_date: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-23-114269 · tm2329795d1_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,502

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F2 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2654 to $0.2671 inclusive. The Reporting Person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon report, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-23-107157 · tm2327750-1_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,383

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

SEC source: 0001104659-23-106379 · tm2327541-1_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,650

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3100 to $0.3129 inclusive. The Reporting Person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon report, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-23-096877 · tm2325166-1_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,865

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3051 to $0.3068 inclusive. The Reporting Person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon report, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-23-094884 · tm2324750-1_4seq1.xml · derivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2033-08-23

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F1 · derivative.exercise_date: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-23-094885 · tm2324750-2_4seq1.xml · derivative · entry 1

Duran Felipe · CIK 0001964267 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2033-08-23

F1 · security: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

F1 · derivative.exercise_date: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

SEC source: 0001104659-23-085306 · tm2322333-1_4seq1.xml · nonDerivative · entry 2

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,876

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

SEC source: 0001104659-23-085306 · tm2322333-1_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,911

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

SEC source: 0001104659-23-080733 · tm2321232-1_4seq1.xml · nonDerivative · entry 1

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,391

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

SEC source: 0001104659-23-075015 · tm2319771-1_4seq1.xml · nonDerivative · entry 2

Brenner Martin · CIK 0001770235 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,411

F2 · kind: Consists of 75,833 shares of the Company's common stock, represented by 75,833 RSUs granted under the Company's 2020 Plan. Each RSU represents a contingent right to receive one share of Common Stock. The 75,833 RSUs vest pro rata over a seven-month period, such vesting to terminate if Dr. Brenner is no longer the Company's Chief Executive Officer